Completed OBSERVATIONAL NCT05355532

Genetic Determinants of the Coronary Microvascular Obstruction in PCI

Identification of Genetic Determinants of the Coronary Microvascular Obstruction Development in Percutaneous Coronary Interventions

Sponsor: Privolzhsky Research Medical University

Conditions Myocardial Infarction No-Reflow Phenomenon

Interventions different variants of SNPs that may be associated with the coronary microvascular obstruction development

Updated 10 times since 2022 Last updated: Jan 27, 2026 Started: Apr 11, 2022 Primary completion: Mar 5, 2023 Completion: Mar 25, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Myocardial Infarction and No-Reflow Phenomenon, this trial is completed. The trial is conducted by Privolzhsky Research Medical University and has accumulated 10 data snapshots since 2022. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

10 versions recorded

Feb 2026 — Present [monthly]

Completed
Oct 2025 — Feb 2026 [monthly]

Completed
Sep 2025 — Oct 2025 [monthly]

Completed
Oct 2024 — Sep 2025 [monthly]

Completed
Sep 2024 — Oct 2024 [monthly]

Completed

▶ Show 5 earlier versions

Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2023 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Dec 2022 — Apr 2023 [monthly]

Recruiting
Nov 2022 — Dec 2022 [monthly]

Recruiting
Jun 2022 — Nov 2022 [monthly]

Recruiting

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Privolzhsky Research Medical University

Data source: Privolzhsky Research Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nizhny Novgorod, Russia